NCT07715097 — Glioblastoma trial site landscape

Public-registry site landscape for NCT07715097, a Glioblastoma study sponsored by Beijing Tricision Biotherapeutics Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07715097 (registry record)
Sponsor	Beijing Tricision Biotherapeutics Inc
Condition(s)	Glioblastoma
Phase	PHASE2
Listed sites	0

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07715097 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.